Teratogenicity of cocaine in humans

https://doi.org/10.1016/S0022-3476(87)80297-4Get rights and content

To study teratogenicity of cocaine in humans, we studied three groups of pregnant women and their offspring: group 1, 50 women who abused cocaine only; group 2, 110 women who were polydrug abusers; and group 3, 340 who were drug free. All three groups were similar for socioeconomic status, cigarette smoking, and ethnicity. Maternal age of group 1 was similar to that of group 3, but group 2 mothers were significantly older. Gravidity was significantly higher in groups 1 and 2 compared with group 3. No statistical difference was found in spontaneous abortion rate among the three groups, but the stillbirth rate was significantly higher in group 1 (ξ2=6.89, P≤0.01). All stillbirths were related to abruptio placentae. Birth weight, length, and head circumference were significantly decreased in infants in groups 1 and 2 compared with group 3 (P≤0.0001), but no statistical difference was found between groups 1 and 2. The congenital malformation rate was significantly higher in group 1 compared with group 3 (ξ2=7.07, P≤0.01). We conclude that cocaine abuse in humans significantly reduces weight of the fetus, increases the stillbirth rate related to abruptio placentae, and is associated with a higher malformation rate.

References (16)

There are more references available in the full text version of this article.

Cited by (377)

  • Passive Addiction and Teratogenic Effects

    2018, Volpe's Neurology of the Newborn
  • Cardiovascular consequences of cocaine use

    2015, Trends in Cardiovascular Medicine
    Citation Excerpt :

    It is presumed that such issues occur as a result of the vasoconstrictive effects of cocaine exposure on the maternal cardiovascular system and uteroplacental blood flow [63]. A five-fold increase in the risk of congenital malformations has been observed in cocaine-exposed pregnancies compared to cocaine-negative controls [63,64]. Recognizing cocaine as the cause of cardiovascular events is important for optimal patient management due to some of the treatment differences described below.

  • Recreational drugs

    2015, Drugs During Pregnancy and Lactation: Treatment Options and Risk Assessment: Third Edition
  • MOTHERISK ROUNDS: Cocaine Abuse During Pregnancy

    2014, Journal of Obstetrics and Gynaecology Canada
    Citation Excerpt :

    However, when this analysis was completed with comparison of mothers who were abusing only cocaine with the drug-free control group, the effect was no longer observed.24 Early reports by Bingol and colleagues suggested that cocaine may act as a teratogen.4 However, this study was limited in its assessment of confounding factors and had some methodological limitations.25,26

  • The manifestation of cocaine-induced midline destructive lesion in bone tissue and its identification in human skeletal remains

    2013, Forensic Science International
    Citation Excerpt :

    Although pups born to mothers administered 100 mg of cocaine daily during pregnancy did not show the same significant effects, they did generally show higher rates of intrauterine and postnatal death prior to measurement than any other group in the study and higher rates of osteopenia than pair-fed controls. Prenatal cocaine exposure is also associated with delayed ossification of paws and the skull in mice and rat pups [109] and with developmental limb and digit anomalies, cranial bone defects (including exencephaly and interparietal encephalocele, and parietal bone defects without herniation), and delayed calvarial ossification in human infants [110,111]. These findings further suggest reduced/impaired osteoblastic activity associated with cocaine use.

View all citing articles on Scopus
View full text